olm26250 / iStockphoto.com
The US Court of Appeals for the Federal Circuit has overturned a reduction in the patent term adjustment (PTA) owned by Supernus Pharmaceuticals.
The rest of this article is locked for subscribers only. Please login to continue reading.
If you don't have a login, you will need to purchase a subscription to gain access to this article, including all our online content. Please use this link and follow the steps.
For multi-user price options, or to check if your company has an existing subscription to us that we can add you to for FREE, please email Atif Choudhury at email@example.com
Supernus Pharmaceuticals, US Court of Appeals for the Federal Circuit, patent term adjustment, Sandoz, patent litigation, pharmaceuticals